Compare CRUS & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRUS | GRFS |
|---|---|---|
| Founded | 1984 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.2B |
| IPO Year | 1989 | 2006 |
| Metric | CRUS | GRFS |
|---|---|---|
| Price | $144.29 | $9.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $147.60 | $10.15 |
| AVG Volume (30 Days) | ★ 814.5K | 449.6K |
| Earning Date | 02-03-2026 | 07-28-2022 |
| Dividend Yield | N/A | ★ 1.53% |
| EPS Growth | ★ 37.60 | N/A |
| EPS | ★ 7.56 | 0.64 |
| Revenue | $1,973,312,000.00 | ★ $8,821,017,248.00 |
| Revenue This Year | $1.37 | $5.36 |
| Revenue Next Year | $2.76 | $5.15 |
| P/E Ratio | $18.79 | ★ $17.85 |
| Revenue Growth | 7.04 | ★ 7.31 |
| 52 Week Low | $75.83 | $6.19 |
| 52 Week High | $146.88 | $11.14 |
| Indicator | CRUS | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 68.02 | 52.06 |
| Support Level | $139.26 | $9.07 |
| Resistance Level | $146.88 | $9.64 |
| Average True Range (ATR) | 6.77 | 0.21 |
| MACD | 0.73 | -0.01 |
| Stochastic Oscillator | 82.83 | 42.47 |
Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.